FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Atropine 500micrograms/5ml solution for injection pre-filled syringes (Aguettant Ltd) 1 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 500micrograms/5ml solution for injection pre-filled syringes (Aguettant Ltd) 10 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Almus Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours transdermal patch VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Andropatch 2.5mg/24hours patches (GlaxoSmithKline) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours transdermal patches 1 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours patches 60 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours transdermal patches (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Andropatch 2.5mg/24hours patches (GlaxoSmithKline) 60 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours transdermal patches (Special Order) 1 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
GentilFoam Border dressing 15cm x 20cm (Aspen Medical Europe Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
GentilFoam Border dressing 15cm x 20cm (Aspen Medical Europe Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
GentilFoam Border dressing 15cm x 20cm (Aspen Medical Europe Ltd) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely tretinoin 100 microgram/1 gram conventional release cutaneous gel VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely tretinoin 500 microgram/1 gram conventional release cutaneous cream VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous gel VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clonazepam 1mg/1ml solution for injection ampoules and diluent VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing with polyurethane foam film backing sterile 15cm x 20cm VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Episil Absorbent dressing 15cm x 20cm (Advancis Medical) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Retin-A 0.025% gel (Janssen-Cilag Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Retinova 0.05% cream (Johnson & Johnson Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing with polyurethane foam film backing sterile 15cm x 20cm 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tretinoin 0.05% cream (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tretinoin 0.025% gel 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing with polyurethane foam film backing sterile 15cm x 20cm 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
GentilFoam dressing 15cm x 20cm (Aspen Medical Europe Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tretinoin 0.05% cream 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tretinoin 0.01% gel (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tretinoin 0.025% gel (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rivotril 1mg/1ml solution for injection ampoules and diluent (Roche Products Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tretinoin 0.05% cream 20 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing with polyurethane foam film backing sterile 15cm x 20cm 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rivotril 1mg/1ml concentrate for solution for injection ampoules and diluent (Imported (France)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tretinoin 0.01% gel 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clonazepam 1mg/1ml solution for injection ampoules and diluent 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tretinoin 0.01% gel 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tretinoin 0.025% gel 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Retinova 0.05% cream (Johnson & Johnson Ltd) 20 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Episil Absorbent dressing 15cm x 20cm (Advancis Medical) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rivotril 1mg/1ml concentrate for solution for injection ampoules and diluent (Imported (France)) 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tretinoin 0.01% gel (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Retin-A 0.01% gel (Janssen-Cilag Ltd) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Retin-A 0.025% gel (Janssen-Cilag Ltd) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rivotril 1mg/1ml solution for injection ampoules and diluent (Roche Products Ltd) 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Episil Absorbent dressing 15cm x 20cm (Advancis Medical) 10 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
GentilFoam dressing 15cm x 20cm (Aspen Medical Europe Ltd) 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tretinoin 0.05% cream (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
GentilFoam dressing 15cm x 20cm (Aspen Medical Europe Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tretinoin 0.025% gel (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Foodlink Complete Starter Pack powder - invalid VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Nutricrem Starter Pack dessert VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Foodlink Complete Starter Pack powder - invalid 291 gram VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Foodlink Complete Starter Pack powder - invalid VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nutricrem Starter Pack dessert (Nualtra Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Nutricrem Starter Pack dessert 375 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Foodlink Complete Starter Pack powder - invalid (Nualtra Ltd) 291 gram 1x(4 x 57g sach+1 x 63g sach) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Nutricrem Starter Pack dessert (Nualtra Ltd) 375 gram 1 x (3 x 125g pots) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Hospira UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Hospira UK Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Selegiline hydrochloride 10mg/5mL syrup VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Human normal immunoglobulin 2.5g infusion solution vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Human normal immunoglobulin 500mg infusion solution vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Chloroquine sulfate 68mg/5mL syrup VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Prothromplex Total 600 powder and solvent for solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Zoledronic acid 5mg/100ml infusion bags VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Caffeine 100mg / Ergotamine 1mg tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gammagard S/D 2.5g powder and solvent for solution for injection bottles (Baxter Healthcare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ergotamine 1mg / Caffeine 100mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gammagard S/D 500mg powder and solvent for solution for injection bottles (Baxter Healthcare Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Prothromplex Total 600 powder and solvent for solution for injection vials 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Zoledronic acid 5mg/100ml infusion bags (A A H Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Selegiline 10mg/5ml oral solution 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Zoledronic acid 5mg/100ml infusion bags (Hospira UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ergotamine 1mg / Caffeine 100mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Selegiline 10mg/5ml oral solution 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cafergot tablets (Alliance Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Normal immunoglobulin human 2.5g powder and solvent for solution for injection bottles 1 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Prothromplex Total 600 powder and solvent for solution for injection vials (Takeda UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Zoledronic acid 5mg/100ml infusion bags 1 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Chloroquine sulfate 68mg/5ml oral solution 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nivaquine 68mg/5ml syrup (Beacon Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Normal immunoglobulin human 500mg powder and solvent for solution for injection bottles 1 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Vigam-S 2.5g powder and solvent for solution for injection bottles (BPL (Bio Products laboratory)) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Selegiline 10mg/5ml oral solution (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Eldepryl 10mg/5ml syrup (Orion Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chloroquine sulphate 68mg/5ml oral solution 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chloroquine sulfate 68mg/5ml oral solution (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Eldepryl 10mg/5ml syrup (Orion Pharma (UK) Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Gammagard S/D 2.5g powder and solvent for solution for injection bottles (Baxter Healthcare Ltd) 1 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Zoledronic acid 5mg/100ml infusion bags (A A H Pharmaceuticals Ltd) 1 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Selegiline 10mg/5ml oral solution (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Vigam-S 2.5g powder and solvent for solution for injection bottles (BPL (Bio Products laboratory)) 1 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ergotamine 1mg / Caffeine 100mg tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cafergot tablets (Alliance Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prothromplex Total 600 powder and solvent for solution for injection vials (Takeda UK Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Gammagard S/D 500mg powder and solvent for solution for injection bottles (Baxter Healthcare Ltd) 1 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Zoledronic acid 5mg/100ml infusion bags (Hospira UK Ltd) 1 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Chloroquine sulfate 68mg/5ml oral solution (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nivaquine 68mg/5ml syrup (Beacon Pharmaceuticals Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 69 of 86 Next End

This concept is not in any reference sets

Back to Start